Understanding immune responses in glioblastoma to enhance treatment outcomes
Dissecting Orchestrated Immune Responses to Glioblastoma within the Native Tissue Microenvironment to Improve Treatment Outcomes
This study is looking at how the immune system and glioblastoma cells work together in the brain, using samples from patients and mice to see how the tumor's location affects how it responds to treatments like radiation and chemotherapy, with the hope of finding better ways to help patients based on their unique tumor features.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Beth Israel Deaconess Medical Center NIH-funded |
| Lab location | 1 site (Boston, United States) |
| Project ID | NIH-11162569 on NIH RePORTER |
What this research studies
This research investigates how the immune system interacts with glioblastoma cells within the tumor microenvironment. By analyzing both human patient samples and mouse models, the study aims to uncover how the location of tumor cells affects their behavior and response to standard treatments like radiation and chemotherapy. The researchers will utilize advanced techniques such as single-cell RNA sequencing to gain insights into the cellular diversity and dynamics of glioblastoma, which could lead to improved therapeutic strategies. Patients may benefit from a better understanding of how their specific tumor characteristics influence treatment effectiveness.
Who could benefit from this research
Good fit: Ideal candidates for this research are patients diagnosed with glioblastoma who are undergoing standard treatment.
Not a fit: Patients with other types of brain tumors or those who are not receiving standard glioblastoma treatments may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective treatment strategies for glioblastoma patients, potentially improving survival rates.
How similar studies have performed: Previous research has shown promise in understanding tumor microenvironments and immune interactions, suggesting that this approach could yield significant insights.
Where this research is happening
Boston, United States
- Beth Israel Deaconess Medical Center — Boston, United States (Active)
Researchers
- Principal investigator: Charest, Alain — Beth Israel Deaconess Medical Center
- Study coordinator: Charest, Alain
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.